While potentially not an issue for the single anti-PD-1/PD-L1 agent, the toxicity of chemotherapy components raises no shortage of concerns for combination chemotherapy plus immunotherapy in octogenarians with advanced NSCLC. Here, CD274 is linked to non-small cell lung carcinoma.